Cohance Lifesciences Share price target & analyst calls
₹461.8+4.10 (+0.90%)
As of 21 Oct 2026
Avg 1-year target
3 of 4 long-term calls BUY₹567.522.9% above today's price
Cohance Lifesciences' average 1-year share price target is ₹567.5, the average of 4 advisors' latest targets. Targets range from ₹365 to ₹845.
Latest: Investec India ₹560 · 21 Oct 2026
6
5 BUY · 1 SELL, all horizons
4
with an active 1Y target
9%
1 of 11 closed calls hit
17
all horizons, open and closed
Watch COHANCE for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
Cohance Lifesciences target price by brokerage
Each advisor's latest 1-year target · 4 advisors · tap a row for the call
All tips (17)
IIbyInvestec India+21.3% to target
1 Year* · 12 mo left · 21 Oct 2026 · entry ₹464.9 · via NDTV Profit (Live)P&L -0.7%
GSbyGoldman Sachs+8.3% to target
1 Year* · 10 mo left · 6 Aug 2026 · entry ₹417.9 · via ET Now (Live)P&L +10.5%
ISbyICICI Securities+21.0% to target
1 Year* · 10 mo left · 6 Aug 2026 · entry ₹438.9 · via Moneycontrol Broker ResearchP&L -5.2%
BCbyBOB Capital Markets+83.0% to target
1 Year* · 3 wk left · 14 Nov 2025 · entry ₹615.5 · via Institutional / Brokerage ResearchP&L -25.0%
BCbyBOB Capital MarketsTarget hit
1 Year* · 13 Feb 2026 · entry ₹315.6 · via Institutional / Brokerage Researchexit ₹414
BCbyBOB Capital MarketsExpired
1 Year* · 14 Aug 2025 · entry ₹913.85 · via Institutional / Brokerage Researchexit ₹444.2
BCbyBOB Capital MarketsExpired
1 Year* · 29 May 2025 · entry ₹1,066.5 · via Institutional / Brokerage Researchexit ₹431.5
ISbyICICI SecuritiesExpired
1 Year* · 29 May 2025 · entry ₹1,066.5 · via Institutional / Brokerage Researchexit ₹431.5
ISbyICICI SecuritiesExpired
1 Year* · 25 Mar 2025 · entry ₹1,175.5 · via Institutional / Brokerage Researchexit ₹306.15
BCbyBOB Capital MarketsExpired
1 Year* · 24 Mar 2025 · entry ₹1,175.5 · via Institutional / Brokerage Researchexit ₹296.3
KSbyKunal Saraogi+14.8% to target
1–3 Months* · 4 wk left · 18 Aug 2026 · entry ₹459.8 · via Zee Business (Live)P&L +0.4%
MKbyMehul Kothari, Anand RathiStop-loss hit
1–3 Months · 20 Aug 2026 · entry ₹477.8 · via Zee Business (Live)exit ₹435
AKbyArun Kumar Mantri+7.2% to target
1–2 Weeks* · 12d left · 21 Oct 2026 · entry ₹468.45 · via CNBC Awaaz.P&L -1.4%
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 7 Oct 2026 · entry ₹463 · via IDBI Capital Research Calls Telegramexit ₹451
RDbyRupak De, LKP SecuritiesStop-loss hit
1–2 Weeks* · 11 Aug 2026 · entry ₹468.6 · via CNBC Awaaz.exit ₹457
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+8.1% · 19 calls
- CIPLACipla Ltd.₹1,524+16.0% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+27.5% · 15 calls
- BIOCONBiocon Ltd₹485+44.8% · 12 calls
- LUPINLupin Limited₹2,576+31.2% · 12 calls
- COHANCE· this stockCohance Lifesciences Limited₹568+22.9% · 4 calls